Fig. 3From: Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)Forest plot for MCD of at least −4 points in total MoCA score. CL confidence limit, EoT end of treatment, LCL lower confidence limit, MCD minimally clinically important difference, MoCA Montreal Cognitive Assessment, N number of observations, RR relative risk ratio, UCL upper confidence limitBack to article page